Expression of multidrug resistance protein in metastatic colorectal carcinomas

Journal of Gastroenterology

Volumn 34, Issue 5, 1999, Pages 582-588

  Nanashima, Atsushi ^a   Yamaguchi, Hiroyuki ^a   Matsuo, Seiji ^a   Sumida, Yorihisa ^a   Tsuji, Takashi ^a   Sawai, Terumitsu ^a   Yasutake, Toru ^a   Nakagoe, Tohru ^a   Ayabe, Hiroyoshi ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Colorectal carcinoma; Liver metastasis; Multidrug resistance protein

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL; MULTIDRUG RESISTANCE PROTEIN; UFT;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; COLORECTAL CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RECTAL DRUG ADMINISTRATION;

AGED; ANALYSIS OF VARIANCE; ANTINEOPLASTIC AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; FEMALE; GENES, MDR; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; PROGNOSIS;

EID: 0032755515     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005350050376     Document Type: Article

References (23)

1. Windle R, Bell PRF, Shaw D. Five year results of a randomized trial of adjuvant 5-fluorouracil and levamisole in colorectal cancer. Br J Surg 1987;74:569-72.
2. NIH Consensus Conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA 1990;1264:1444-50.
3. Moertel CG, Fleming TR, MacDonald JS, Haller DG, Laurie JA, Tangen CM, et al. Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report. Ann Intern Med 1995;122:321-6.
4. Gastrointestinal Tumor Study Group. Adjuvant therapy of colon cancer: results of a prospectively randomized trial. N Engl J Med 1984;310:737-43.
5. Abdi E, Harbora D, Hanson J, Young DG, McPherson TA. Adjuvant chemoimmuno and immunotherapy in stage B2 and C colorectal cancer. Proc Am Soc Clin Oncol 1987;6:93.
6. The Colorectal Cancer Chemotherapy Study Group of Japan. Five-year results of a randomized controlled trial of adjuvant chemotherapy for curatively resected colorectal carcinoma. Jpn J Clin Oncol 1995;25:91-103.
7. Pinson CW, Wright JK, Chapman WC, Garrard CL, Blair TK, Sawyers JL. Repeat hepatic surgery for colorectal cancer metastasis to the liver. Ann Surg 1996;223:765-76.
8. Wittes RE, Goldin A. Unresolved issues in combination chemotherapy. Cancer Treat Rep 1986;70:105-25.
9. Goldstein LJ, Galski H, Fojo A, Willingham M, Lai SL, Gazdar A, et al. Expression of a multidrug resistance gene in human cancers. J Natl Cancer Inst 1989;81:116-24.
10. Cole SP, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, et al. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 1992;258: 1650-4.
11. Filipits M, Suchomel RW, Dekan G, Stiglbauer W, Haider K, Depisch D, et al. Expression of the multidrug resistance-associated protein (MRP) gene in colorectal carcinomas. Br J Cancer 1997;75:208-12.
12. Takebayashi Y, Akiyama SI, Natsugoe S, Hokita S, Niwa K, Kitazono M, et al. The expression of multidrug resistance protein in human gastrointestinal tract carcinomas. Cancer 1998;82:661-6.
13. Chuman Y, Sumizawa T, Takebayasi Y, Niwa K, Yamada K, Haraguchi M, et al. Expression of the multidrug resistance-associated protein 8mrp9 gene in human colorectal, gastric and non-small cell lung carcinomas. Int J Cancer 1996;66:274-9.
14. Japanese Society for Cancer of the Colon and Rectum. Japanese Classification of Colorectai Carcinoma. 1st ed. Tokyo: Kanehara; 1997. p. 18.
15. Bordow SB, Haber M, Madafiglio J, Cheung B, Marshall GM, Norris MD. Expression of the multidrug resistance-associated protein (MRP) gene correlates with amplification and overexpression of the N-myc oncogene in childhood neuroblastoma. Cancer Res 1994;54:5036-40.
16. Sugawara I, Yamada H, Nakamura H, Sumizawa T, Akiyama S, Masunaga A, et al. Preferential expression of the multidrug resistance-associated protein (MRP) in adenocarcinoma of the lung. Int J Cancer 1995;64:322-5.
17. Nooter K. Expression of the multidrug resistance-associated protein (MRP) gene in human cancers. Clin Cancer Res 1995;1: 1301-10.
18. Machover D. A comprehensive review of 5-fluorouracil and leucovorin in patients with metastatic colorectal carcinoma. Cancer 1997;80:1179-87.
19. Vauthey JN, Marsh RW, Cendan JC, Chu NM, Copeland EM. Arterial therapy of hepatic colorectal metastases. Br J Surg 1996;83:447-55.
20. Suzuki S, Nakamura S, Ochiai H, Konno H, Baba S, Baba S, et al. Surgical management of recurrence after resection of colorectal liver metastases. J Hep Bil Pancr Surg 1997;4:103-12.
21. Licht T, Fiebig HH, Bross KJ, Herrmann F, Berger DP, Shoemaker R, et al. Induction of multiple-drug resistance during antineoplastic chemotherapy in vitro. Int J Cancer 1991;49:630-7.
22. Norris MD, Bordow BS, Marshall GM, Haber PS, Cohn SL, Haber M. Expression of the gene for multidrug resistance-associated protein and outcome in patients with neuroblastoma. N Engl J Med 1996;334:231-8.
23. Thomas GA, Barrand MA, Stewart S, Rabbitts PH, Williams ED, Twentyman PR. Expression of the multidrug resistance-associated protein (MRP) gene in human lung tumours and normal tissue as determined by in situ hybridization. Eur J Cancer 1994;30A:1705-9.